Core Viewpoint - Health 160 (02656) has seen a significant stock price increase of over 343% since its IPO, reaching a new high of 52.8 HKD, compared to its initial offering price of 11.89 HKD [1] Company Overview - Health 160 is an experienced wholesale distributor of pharmaceutical and health products in China, as well as a leading provider of integrated digital healthcare services [1] - The company offers a wide range of pharmaceutical health products and comprehensive digital healthcare solutions [1] Market Performance - As of the latest report, Health 160's stock is up 6.14%, trading at 52.75 HKD with a transaction volume of 31.5488 million HKD [1] Operational Metrics - Since its establishment, Health 160 has connected with over 44,600 healthcare institutions, including more than 14,400 hospitals (of which 3,430 are tertiary hospitals) and over 30,200 grassroots healthcare institutions, as of March 31, 2025 [1]
港股异动 | 健康160(02656)涨超6%再创新高 上市两个月股价累涨超三倍